Monthly revenue and year-on-year change for Mycenax Biotech (4726) and PEC (6446) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.
Year-on-year change
Monthly revenue history
| Month | Mycenax Biotech | YoY | PEC | YoY |
|---|---|---|---|---|
| Oct 2026 | NT$98 million | +41.0% | NT$2.84 billion | +102.0% |
| Sep 2026 | NT$116.4 million | +393.3% | NT$2.64 billion | +100.0% |
| Aug 2026 | NT$105.9 million | +131.4% | NT$2.62 billion | +105.4% |
| Jul 2026 | NT$86 million | +38.6% | NT$2.51 billion | +92.6% |
| Jun 2026 | NT$53.8 million | -48.9% | NT$2.33 billion | +94.9% |
| May 2026 | NT$42.5 million | -39.7% | NT$2.46 billion | +108.5% |
| Apr 2026 | NT$106.7 million | +301.0% | NT$2.06 billion | +68.3% |
| Mar 2026 | NT$94.6 million | +78.6% | NT$1.94 billion | +64.4% |
| Feb 2026 | NT$56.6 million | +140.4% | NT$1.6 billion | +56.7% |
| Jan 2026 | NT$45.7 million | +0.9% | NT$1.58 billion | +49.8% |
| Dec 2025 | NT$127.3 million | +156.4% | NT$1.92 billion | +69.9% |
| Nov 2025 | NT$87.8 million | -19.5% | NT$1.55 billion | +53.0% |
| Oct 2025 | NT$69.5 million | +97.1% | NT$1.4 billion | +53.6% |
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16